SEC Form 4 · accession 0001796789-26-000004
LENZ Therapeutics, Inc. · LENZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey P. George
Director
Period of report
Jun 15, 2026
Accepted (ET)
Jun 15, 2026 · 8:18 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001815776
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $6.63 | Jun 15, 2026 | A | 22,100 | A | — | Jun 15, 2036 | Common Stock | 22,100 | 22,100 | D |
Explanation of responses
- F1Subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's Outside Director Compensation Policy) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier to occur of June 15, 2027 or the date of the next annual meeting of stockholders.